Search results
Results from the WOW.Com Content Network
CRISPR Therapeutics (NASDAQ: CRSP) isn't a stock that's wanting for reasons to invest. Per the company's presentation at the American Society of Hematology's (ASH) annual meeting on Dec. 9, the ...
The biotech recently became a commercial-stage company. ... CRISPR Therapeutics Stock Could Be a Millionaire-Maker. ... Its price in the U.S. is $2.2 million. Its total addressable market includes ...
CRISPR Therapeutics has a $3.9 billion market cap at recent prices, but the stock is less expensive than it looks on the surface. With a big cash cushion and a lack of debt, its enterprise value ...
It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. [ 2 ] [ 3 ] The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom.
For premium support please call: 800-290-4726 more ways to reach us
Stock name Symbol Country of origin X Financial XYF: China: XAI Octagon Floating Rate & Alternative Income Trust XFLT: United States: XAI Octagon Floating Rate & Alternative Income Trust XFLT.PRA: United States Xenia Hotels & Resorts, Inc. XHR: United States Xinyuan Real Estate Co., Ltd. XIN: China XPeng Inc. XPEV: China Xperi Inc. XPER: United ...
Stock name Symbol Country of origin Nabors Industries: NBR: United States: NACCO Industries: NC: United States: Nam Tai Property Inc. NTP: Hong Kong: National Bank Holdings Corporation NBHC: United States: National Bank of Greece: NBG: Greece: National Fuel Gas: NFG: United States: National Grid plc: NGG: United Kingdom: National Health ...
For premium support please call: 800-290-4726 more ways to reach us